In a discussion two years ago, I said that if China and India embargoed raw materials for medicines (BBO) on Indonesia, the Indonesian pharmaceutical industry would only be able to survive for six months.
·1 menit baca
The Indonesian pharmaceutical industry has no resilience because it is highly dependent on the raw material for medicines from the two countries. Indonesia’s BBO imports from China is 63 percent, India 23 percent, and the rest are from other countries.
The dependence is not only on active [...]